Profile
Yoshiaki Endo is a Director of Aphoenix, Inc. Mr. Endo is a Venture Capitalist of Tokyo Small & Medium Business Invst & Consultation Co., Ltd.
Prior to joining Aphoenix, Inc., he worked at Mitsui Marine & Fire Insurance Co. Ltd.
for over 7 years.
Mr. Endo received a BSc degree from Waseda University in 1995.
Former positions of Yoshiaki Endo
| Companies | Position | End |
|---|---|---|
Mitsui Marine & Fire Insurance Co. Ltd.
 Mitsui Marine & Fire Insurance Co. Ltd. Property/Casualty InsuranceFinance Part of MS&AD Insurance Group Holdings, Inc., Mitsui Marine & Fire Insurance Co. Ltd. provides property and casualty insurance products. The private company is based in Tokyo, Japan. | Corporate Officer/Principal | - |
Aphoenix, Inc.
 Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Director/Board Member | - |
Training of Yoshiaki Endo
| Waseda University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Mitsui Marine & Fire Insurance Co. Ltd.
Mitsui Marine & Fire Insurance Co. Ltd. Property/Casualty InsuranceFinance Part of MS&AD Insurance Group Holdings, Inc., Mitsui Marine & Fire Insurance Co. Ltd. provides property and casualty insurance products. The private company is based in Tokyo, Japan. | Finance |
Aphoenix, Inc.
Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Health Services |
- Stock Market
- Insiders
- Yoshiaki Endo